Shanghai, China

Jian Li

USPTO Granted Patents = 194 

 

Average Co-Inventor Count = 6.2

ph-index = 7

Forward Citations = 232(Granted Patents)

Forward Citations (Not Self Cited) = 197(Dec 10, 2025)


Inventors with similar research interests:


Company Filing History:

goldMedal32 out of 65 
 
Medshine Discovery Inc.
 patents
silverMedal17 out of 41,376 
 
Qualcomm Incorporated
 patents
bronzeMedal13 out of 118 
 
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
 patents
410 out of 27,156 
 
Huawei Technologies Co., Limited
 patents
59 out of 3,092 
 
Chinese Academy of Sciences
 patents
68 out of 13 
 
Guangdong Raynovent Biotech Co., Ltd.
 patents
76 out of 368 
 
Shanghai Jiao Tong University
 patents
86 out of 7 
 
Duality Biologics (suzhou) Co., Ltd.
 patents
96 out of 15 
 
Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd.
 patents
106 out of 8 
 
Zhuhai United Laboratories Co., Ltd.
 patents
115 out of 5 
 
Wuxi Biocity Biopharmaceutics Co., Ltd.
 patents
124 out of 10 
 
Shandong Danhong Pharmaceutical Co., Ltd.
 patents
133 out of 31 
 
Cspc Zhongqi Pharmaceutical Technology (shijiazhuang) Co., Ltd.
 patents
143 out of 2,208 
 
Nokia Solutions and Networks Oy
 patents
153 out of 84 
 
Savant Technologies LLC
 patents
163 out of 17 
 
Consumer Lighting (u.s.), LLC
 patents
173 out of 5 
 
Shijiazhuang Sagacity New Drug Development Company, Ltd.
 patents
183 out of 3 
 
Guangzhou Joyo Pharmatech Co., Ltd.
 patents
192 out of 273 
 
Ge Lighting Solutions LLC
 patents
202 out of 207 
 
Fudan University
 patents
212 out of 4 
 
Harbin Zhenbao Pharmaceutical Co., Ltd.
 patents
222 out of 3 
 
Fujian Cosunter Pharmaceutical Co., Ltd.
 patents
232 out of 5 
 
Genfleet Therapeutics (shanghai) Inc.
 patents
242 out of 2 
 
Helioeast Science & Technology Co., Ltd.
 patents
252 out of 4 
 
Wuxi Fortune Pharmaceutical Co., Ltd
 patents
262 out of 5 
 
Guangdong Zhongsheng Pharmaceutical Co., Ltd
 patents
272 out of 2 
 
Changzhou Yinsheng Pharmaceutical Co., Ltd.
 patents
282 out of 235 
 
Sichuan University
 patents
292 out of 2 
 
Jumbo Drug Bank Co., Ltd.
 patents
301 out of 2 
 
Pericom Technology (shanghai) Co., Ltd.
 patents
311 out of 11 
 
Qilu Pharmaceutical Co., Ltd.
 patents
321 out of 51,886 
 
General Electric Company
 patents
331 out of 6 
 
Cisen Pharmaceutical Co., Ltd.
 patents
341 out of 4 
 
Zhongshan Ophthalmic Center, Sun Yat-sen University
 patents
351 out of 60 
 
Nokia Shanghai Bell Co., Ltd
 patents
361 out of 2 
 
Phaeno Therapeutics Co., Ltd.
 patents
371 out of 825 
 
Firmenich Sa
 patents
381 out of 11 
 
Nanjing Sanhome Pharmaceutical Co., Ltd.
 patents
391 out of 2 
 
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Baiyunshan Pharmaceutical General Factory
 patents
401 out of 2 
 
Shenzhen Optimum Biological Technology Co., Ltd
 patents
411 out of 2 
 
Wuxi Life Fountain Biotech Co., Ltd
 patents
421 out of 5 
 
Cgenetech (suzhou, China) Co., Ltd.
 patents
431 out of 3,430 
 
Sony Group Corporation
 patents
441 out of 7 
 
Fujian Akeylink Biotechnology Co., Ltd.
 patents
451 out of 1 
 
Novaonco Js Therapeutics Co., Ltd.
 patent
461 out of 5,655 
 
Nokia Technologies Oy
 patents
471 out of 5 
 
Luoxin Pharmaceutical (shanghai) Co., Ltd.
 patents
481 out of 6 
 
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
 patents
491 out of 1 
 
Helioeast Pharmaceutical Co., Ltd.
 patent
501 out of 2 
 
Tasly Biopharmaceuticals Co., Ltd.
 patents
511 out of 12 
 
Commercial Aircraft Corporation of China, Ltd.
 patents
521 out of 8 
 
Commercial Aircraft Corporation of China, Ltd. Shanghai Aircraft Design and Research Institute
 patents
531 out of 600 
 
Delta Electronics (shanghai) Co., Ltd
 patents
541 out of 1 
 
Cspc Zhongqi Pharmaceuticall Technology (shijiazhuang) Co., Ltd.
 patent
551 out of 3 
 
Simcere Pharmaceutical Co., Ltd.
 patents
561 out of 2 
 
China Resources Pharmaceutical Holdings Company Limited
 patents
571 out of 1 
 
Shliazhuang Sagacity New Drug Development Co., Ltd.
 patent
581 out of 1 
 
Chongqing Pharmaceutical Industrial Research Institute Co. Ltd.
 patent
591 out of 5 
 
Yaopharma Co., Ltd.
 patents
601 out of 3 
 
Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd.
 patents
611 out of 20 
 
Shandong Luye Pharmaceutical Co., Ltd.
 patents
621 out of 1 
 
Guizhou Inochini Technology Co., Ltd
 patent
631 out of 590 
 
Electronic Arts Inc.
 patents
641 out of 8 
 
Cstone Pharmaceuticals
 patents
651 out of 2 
 
Cstone Pharmaceutical (suzhou) Co., Ltd.
 patents
661 out of 7 
 
Cstone Pharmaceuticals (shanghai) Co., Ltd.
 patents
671 out of 125 
 
East China University of Science and Technology
 patents
681 out of 104 
 
Synamedia Limited
 patents
691 out of 16 
 
Jiangsu Kanion Pharmaceutical Co., Ltd.
 patents
701 out of 1 
 
Zhejiang Longcharm Bio-tech Pharma. Co., Ltd.
 patent
711 out of 3 
 
D3 Bio (wuxi) Co., Ltd.
 patents
721 out of 3 
 
Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
 patents
731 out of 2 
 
Shanghai Marine Equipment Research Institute
 patents
741 out of 4 
 
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
 patents
754 out of 832,718 
Other
 patents
where one patent can have more than one assignee

Years Active: 2002-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Raptor Codes
Retinal Diseases
Atr Inhibitor
Dual Sim Device
Orbital Angular Momentum Beams
Anti-Tumor Compounds
Fgfr Inhibitors
Wireless Communication
Polar Codes
Irak4 Inhibitors
Pharmaceutical Compounds
Error Detection Techniques
194 patents (USPTO):Explore Patents

Title: Jian Li: Shanghai's Innovator with Over 133 Patents

Introduction:

In the realm of innovation and patents, Jian Li has made a significant impact with his extensive portfolio of patents and groundbreaking inventions. Based in Shanghai, China, Li's contributions have made him a notable figure within the industry. This article explores Li's latest patents, career highlights, and collaborative endeavors.

Latest Patents:

Jian Li has recently unveiled two impressive patents, showcasing his expertise in the field:

1. Benzo 2-azaspiro[4.4]nonane compound and use thereof:

This patent discloses a series of benzo 2-azaspiro[4.4]nonane compounds, with a special emphasis on a specific compound represented by formula (P) or its pharmaceutically acceptable salts. These compounds hold potential for various pharmaceutical applications.

2. Crystal form of 2-methyl-2-propanol and amino-substituted aryl compound:

Another notable patent by Li involves a crystal form (such as formula I) of a 2-methyl-2-propanol and amino-substituted aryl compound, along with its preparation method. This crystal form finds application in the development of medicines to treat related diseases.

Career Highlights:

Throughout his career, Jian Li has made significant strides in the field of innovation. Here are some career highlights:

1. Medshine Discovery Inc.:

Li has been associated with Medshine Discovery Inc., a prominent pharmaceutical research and development company. His contributions to the company have played a crucial role in advancing drug discovery and development processes.

2. Chia Tai Tianqing Pharmaceutical Group:

Li has also worked with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. This collaboration demonstrates his commitment to partnering with influential industry players to bring innovative healthcare solutions to the market.

Collaborations:

Jian Li has actively engaged in collaborations with fellow professionals, fostering a collective spirit of innovation and knowledge sharing. Notably, he has collaborated closely with Shuhui Chen, a respected figure in the field. Their joint efforts have led to groundbreaking advancements and further established Li's position as a leading innovator.

Conclusion:

Jian Li's impressive collection of over 133 patents and notable career highlights clearly depict his commitment to innovation and expertise in the pharmaceutical field. With his recent patents focusing on new compounds and crystal forms with medical applications, Li continues to make a significant impact. Collaborations with industry leaders like Shuhui Chen further solidify his standing as a respected innovator. As Shanghai's own innovator, Jian Li is undoubtedly shaping the future of the pharmaceutical industry with his inventive contributions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…